Bromodomain Inhibitors in Degenerative Eye Disease; An Alternative to VEGF Inhibitors in Macular Degeneration?

World Journal of Ophthalmology & Vision Research
doi 10.33552/wjovr.2020.03.000553
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Iris Publishers LLC

Related search

BET Bromodomain Inhibitors Synergize With ATR Inhibitors in Melanoma in Melanoma

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2017English

Age-Related Macular Degeneration-An Emerging and Re-Emerging Eye Blinding Disease

Journal of the Nigerian Optometric Association
2010English

Vascular Endothelial Growth Factor Inhibitors in the Treatment of Neovascular Age-Related Macular Degeneration

Vestnik Oftalmologii
MedicineOphthalmology
2017English

Genetic Biomarkers in the VEGF Pathway Predicting Response to Anti-Vegf Therapy in Age-Related Macular Degeneration

BMJ Open Ophthalmology
Ophthalmology
2019English

Alternative Therapies in Exudative Age Related Macular Degeneration

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
1998English

Rational Design Platform to Generate Dual-Acting Kinase and Bromodomain Inhibitors

Science-Business eXchange
2014English

Does Genetic Variation Influence Response to Treatment With Vascular Endothelial Growth Factor Inhibitors in Neovascular Age-Related Macular Degeneration?

Ophthalmic Epidemiology
EpidemiologyOphthalmology
2014English

Dual Antagonism of PDGF and VEGF in Neovascular Age-Related Macular Degeneration

Ophthalmology
Ophthalmology
2017English

Applying 89Zr-Transferrin to Study the Pharmacology of Inhibitors to BET Bromodomain Containing Proteins

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy